Journal of Pancreatic Cancer and Treatment

Dr. Richard C Frank is a full time medical oncology/hematology practice and serves as Director of Cancer Research for the Western CT Health Network, which runs investigator initiated, and phase I-III cooperative group and pharmaceutical trials. He is also a Clinical Assistant Professor of Medicine at Weill Cornell Medical College, New York, USA. Previously Dr. Frank was an attending physician at Memorial Sloan Kettering Cancer Center, where he had an NIH grant to investigate the role of transcription factors in AML. Dr. Frank was recognized as a Top Doc in the Newyork metro area by Castle Connolly and he is the author of the book "Fighting Cancer with Knowledge and Hope" (Yale Press 2013), which uniquely explains to patients what cancer is and why oncologists choose the therapies we do. He has maintained patient-oriented blogs on cancer for WebMD, Yale Press, CURE and other online journals. Dr. Frank's research interests in pancreatic cancer include 1) translational work investigating the role of non-coding RNA and ct DNA as diagnostic and prognostic markers, 2) novel therapeutics for advanced disease and 3) development of a screening program for high risk individuals.

Dr. Masaru Miyazaki is a director and Professor of IUHW Mita Hospital, and Vice President of International University of Health and Welfare, Japan. He graduated from School of Medicine, Chiba University in 1975, and trained at General Surgery of the First Department Chiba University as a surgical resident and fellow till 1981. Masaru Miyazaki went to Toronto University as a research fellow in 1981, and stayed 2 years under Prof. Rudy Falk. He has been working at Department of General Surgery, Chiba University since 1983, and he was promoted to Professor and Chairman in 2001, also Director of Chiba University Hospital and the Vice-President of Chiba University in 2011. Dr. Miyazaki has been a president of the Society of Japan Hepatobiliary-Pancreatic Surgery since 2012. He hosted 112th Annual meeting of Japan Surgical Society in 2012, also 49th Annual meeting of Japan Biliary Society in 2013, as a president of congress. He received an award of; Japanese Society for Advancement of Surgical Techniques Research Encouragement Award 1997, Japanese Society of Gastroenterological Surgery Art of the Year, Section of Surgery 2015, and 25th Indian Association of Surgical Gastroenterology Conference Pune 2015 for delivering the IASG-AIG Oration at XXV National Conference, Pune, 2015. Dr. Miyazaki's research intrests include HPB (Hepatopancreatobiliary) malignancy, HPB surgery, Liver transplantation.

Dr. Huey-Jen Lin is an Associate Professor of Medical Laboratory Sciences at University of Delaware, Delaware, and Ohio State University, Ohio, USA. Dr. Lin received education in the areas of Biochemistry, Immunology, and Virology, for earning the respective degrees in BS, MS and PhD. Not only was she an educator teaching courses including clinical microbiology, pathophysiology of infectious diseases, genetics as well as molecular diagnosis, she vigorously researched the molecular and epigenetic causes underlying human breast and pancreatic cancer. Dr. Lin's research interests is to Examine how epigenetically silenced tumor suppressor genes influence tumor initiation, progression and metastasis in breast and pancreatic cancers. Her long-term research objective is to examine how aberrant signaling molecules regulate epigenomes and lead to a wide spectrum of malignant phenotypes, primarily in breast and pancreatic cancers. The ultimate goals are: to identify the micro environmental cause (s) leading to tumorigenesis, decipher how dysregulated signaling pathways contribute to neoplasm by altering epigenomes, discover potential diagnostic bio-markers, and develop specific therapeutic strategies by correcting signaling molecules.

Dr. Jaime Ruiz-Tovar is a General and Digestive Surgeon at University Hospital Rey Juan Carlos, Madrid, Spain; where he is specialized in bariatric surgery. He is also Professor of Surgery at Universidad Rey Juan Carlos and Secretary of the Surgical Infections Section of the Spanish Surgical Society. He is Head of the Bariatric Surgery section of the ERAS-Spain group (Enhanced Recovery After Surgery). Dr. Ruiz actually leads several investigational projects focused on bariatric surgery and surgical infections. Dr. Ruiz's research interests includes Sleeve gastrectomy, Metabolic effect of bariatric surgery, Electrical neuro stimulation as alternative bariatric procedures, Prophylactic measures.against surgical site infection.

Dr. Dezso Kelemen is a Full Professor of Pancreatic Surgery at University of Pecs in Hungary. Dr. Kelemen completed his Diploma in Medical University of Debrecen, Hungary. Since 1988 he is working in hospital sector, which is an university teaching hospital with several specialties. His main field is gastro intestinal surgery, mainly pancreatic surgery. Besides he also treat patients with stomach, colon and liver diseases. In 2008 he investigated new techniques in pancreatic surgery, and in 2016 he investigated new techniques in pancreatic surgery under the sponsorship of "Alexander von Humboldt" Fellowship from the University of Heidelberg, Germany.

Dr. Allyson J Ocean is an Associate Professor of Clinical Medicine at Weill Cornell Medical College-New York Presbyterian Hospital in New York, USA. She is also a Consultant and Associate Professor of Medicine at Hospital for Special Surgery; Staff Gastrointestinal Oncologist at The Jay Monahan Center for Gastrointestinal Health, New York. Dr. Ocean is a member of the Pancreatic Cancer Research Team (PCRT), and a co-founder of Let's Win PC! (www.letswinpc.org), a digital platform connecting patients to science in pancreatic cancer. Dr. Ocean is an active member of ASCO and AACR, and is currently leading numerous clinical trials in pancreatic cancer. Dr. Ocean is an ad hoc reviewer for numerous peer-reviewed journals including Journal of Clinical Oncology, Cancer, Journal of Gastrointestinal Cancer, and The Lancet Oncology. Dr. Ocean's gastrointestinal oncology practice focuses on treating gastrointestinal malignancies, including pancreatic, colorectal, stomach, biliary, neuroendocrine, and liver cancers.

Dr. Amy H Tang is a Full Professor of Cancer Biology at the Leroy T. Canoles Jr. Cancer Research Center at Eastern Virginia Medical School. Dr. Tang had worked as a Tenure-Track Assistant Professor in the Department of Surgery at the Mayo Clinic for eight years, where she witnessed the ineffective treatment regimens, dismal prognosis, and devastation of pancreatic cancer firsthand. Since then, Dr. Tang has dedicated her scientific life to training her fellows and graduate students to conduct the highest quality research, and finding innovative and breakthrough strategies to control and eradicate metastatic pancreatic cancer in our lifetimes.